Lorraine von Eeden
Pediatrics · Bronx, NYNPI 1609946805
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $115.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Boehringer Ingelheim$1K
- Novo Nordisk$990
- Otsuka America Pharmaceutical, Inc.$959
- Lilly USA, LLC$611
- plus $7K from 33 others
What the payments were for
- Food & beverage$14,251100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $2,215 |
| Johnson & Johnson | 13 | $1,597 |
| Boehringer Ingelheim | 9 | $1,001 |
| Novo Nordisk | 9 | $990 |
| Otsuka America Pharmaceutical, Inc. | 9 | $959 |
| Lilly USA, LLC | 7 | $611 |
| Teva Pharmaceuticals USA, Inc. | 4 | $505 |
| Axsome Therapeutics, Inc. | 4 | $500 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $465 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $347 |
| Genentech USA, Inc. | 2 | $296 |
| Mannkind Corporation | 2 | $260 |
| Grifols USA, LLC | 3 | $256 |
| Sanofi | 2 | $253 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $253 |
| AstraZeneca | 2 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $249 |
| Coloplast | 2 | $241 |
| Gilead | 2 | $225 |
| Alkermes, Inc. | 2 | $221 |
| Seagen Inc. | 2 | $216 |
| Biogen | 2 | $193 |
| Sequel Med Tech, LLC | 1 | $157 |
| Averitas Pharma Inc. | 1 | $154 |
| Scpharmaceuticals Inc. | 1 | $150 |
| Insulet Corporation | 1 | $150 |
| Biomerieux Inc | 1 | $142 |
| Abbott | 1 | $134 |
| Agios Pharmaceuticals, Inc. | 1 | $128 |
| Bayer | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Dynavax Technologies Corporation | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| UCB, Inc. | 1 | $125 |
| GSK | 1 | $123 |
| Viatris Specialty LLC | 1 | $122 |
| Amgen | 1 | $118 |
| Sanofi-aventis U.S. LLC | 1 | $104 |
| Organon | 1 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$1,097
- JARDIANCE$991
- INVEGA SUSTENNA$765
- SPRAVATO$651
- VRAYLAR$614
- INVEGA TRINZA$519
- ABILIFY MAINTENA$500
- Auvelity$500
- LYBALVI$467
- KISUNLA$348
- UZEDY$267
- AFREZZA$260
- Skyrizi$258
- DUPIXENT$253
- CAPLYTA$253
- ABILIFY ASIMTUFII$250
- Ozempic$250
- RYBELSUS$247
- UBRELVY$246
- TWIIST$157
How this compares
$14,261 in reported general payments places this provider in the 95th percentile of 4,055 pediatrics providers in New York.
Other pediatrics in Bronx
- Philip OzuahBronx$1M
- Acklema MohammadBronx$34K
- Kimberly ReidyBronx$14K
- Daniel RodriguezBronx$11K
- Michael PichicheroRochester$168K
- Patrick SchnellBrooklyn$164K
- Warren SeigelBrooklyn$162K
- Rachael PhelpsRochester$156K
- Sarita GeorgeMineola$90K
- Kathryn FitzgeraldNew York$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.